| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| G7N4L2 | Extracellular sulfatase Sulf-2; Extracellular sulfatase Sulf-2 isoform a; | SULF2; | NULL | 870 | Rhesus-monkey |
| F7A635 | Keratin, type I cytoskeletal 19; Uncharacterized protein; | LOC707129; KRT19; | NULL | 400 | Rhesus-monkey |
| I0FVY6 | MAP kinase-activating death domain protein isoform a; | MADD; | NULL | 1588 | Rhesus-monkey |
| F6WS52 | Uncharacterized protein; | SH2D1B; | XP_001118174.1; | 132 | Rhesus-monkey |
| C1KJY1 | Beta-2-microglobulin; Fragment; | B2M; | NULL | 93 | Rhesus-monkey |
| H9FP30 | Neuropathy target esterase isoform b; | PNPLA6; | NULL | 1326 | Rhesus-monkey |
| Q09H41 | C-X-C chemokine receptor type 6; Fragment; | CXCR6; | NULL | 275 | Rhesus-monkey |
| H9YWR2 | Myelin protein zero-like protein 1 isoform a; | MPZL1; | XP_001089242.1; | 269 | Rhesus-monkey |
| G7NLK9 | Zinc finger protein 574; | ZNF574; | NULL | 896 | Rhesus-monkey |
| H9FYY7 | Serine/threonine-protein kinase 3; | STK3; | NP_001247896.1; | 491 | Rhesus-monkey |
| B6EZW9 | Methionine sulfoxide reductase A; Fragment; | MSRA; | NULL | 35 | Rhesus-monkey |
| F6PMM4 | Uncharacterized protein; | NCEH1; | XP_001084048.1; | 440 | Rhesus-monkey |
| F6Q5M3 | TBC1 domain family member 21; Uncharacterized protein; | TBC1D21; | XP_001094550.1; | 336 | Rhesus-monkey |
| F6T7B4 | Uncharacterized protein; | ARMC5; | XP_002802507.1; | 772 | Rhesus-monkey |
| F6W2N1 | Transmembrane protein 100; Uncharacterized protein; | TMEM100; | NP_001181178.1;XP_002800469.1; | 134 | Rhesus-monkey |
| F7BCK9 | Lysosome-associated membrane glycoprotein 2 isoform B; Uncharacterized protein; | LAMP2; | NP_001247737.1; | 410 | Rhesus-monkey |
| F7GJR4 | Ribonuclease H1; Uncharacterized protein; | RNASEH1; | NP_001244787.1; | 286 | Rhesus-monkey |
| F7FE52 | TP53-inducible gene 5 protein; Uncharacterized protein; | TP53TG5; | NP_001181345.1; | 290 | Rhesus-monkey |
| F6WJ21 | Uncharacterized protein; Uncharacterized protein C11orf46; | ARL14EP; C11orf46; | NP_001248088.1; | 260 | Rhesus-monkey |
| F7H2R6 | Cell division cycle protein 123 homolog; Cell division cycle protein 123-like protein; Uncharacterized protein; | CDC123; | NP_001253583.1; | 336 | Rhesus-monkey |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |